Posted inHealth

Anthem links rate hike proposal to Hepatitis C drugs, state law

Updated 1:50 p.m. Anthem Blue Cross and Blue Shield officials said Friday that the company needs to raise rates on its individual-market policies by an average of 12.5 percent to account for rising pharmaceutical costs, particularly costly new Hepatitis C drugs. Customers, meanwhile, blasted the company for proposing to raise prices on coverage they say is already unaffordable.